255 related articles for article (PubMed ID: 36649710)
1. The NLRP1 and CARD8 inflammasomes detect reductive stress.
Wang Q; Hsiao JC; Yardeny N; Huang HC; O'Mara CM; Orth-He EL; Ball DP; Zhang Z; Bachovchin DA
Cell Rep; 2023 Jan; 42(1):111966. PubMed ID: 36649710
[TBL] [Abstract][Full Text] [Related]
2. Protein folding stress potentiates NLRP1 and CARD8 inflammasome activation.
Orth-He EL; Huang HC; Rao SD; Wang Q; Chen Q; O'Mara CM; Chui AJ; Saoi M; Griswold AR; Bhattacharjee A; Ball DP; Cross JR; Bachovchin DA
Cell Rep; 2023 Jan; 42(1):111965. PubMed ID: 36649711
[TBL] [Abstract][Full Text] [Related]
3. The NLRP1 and CARD8 inflammasomes.
Taabazuing CY; Griswold AR; Bachovchin DA
Immunol Rev; 2020 Sep; 297(1):13-25. PubMed ID: 32558991
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of filament formation in UPA-promoted CARD8 and NLRP1 inflammasomes.
Robert Hollingsworth L; David L; Li Y; Griswold AR; Ruan J; Sharif H; Fontana P; Orth-He EL; Fu TM; Bachovchin DA; Wu H
Nat Commun; 2021 Jan; 12(1):189. PubMed ID: 33420033
[TBL] [Abstract][Full Text] [Related]
5. Oxidized thioredoxin-1 restrains the NLRP1 inflammasome.
Ball DP; Tsamouri LP; Wang AE; Huang HC; Warren CD; Wang Q; Edmondson IH; Griswold AR; Rao SD; Johnson DC; Bachovchin DA
Sci Immunol; 2022 Nov; 7(77):eabm7200. PubMed ID: 36332009
[TBL] [Abstract][Full Text] [Related]
6. The CARD8 T60 variant associates with NLRP1 and negatively regulates its activation.
Xu Z; Deng S; Huang Y; Yang Y; Sun L; Liu H; Zhao D; Zeng W; Yin X; Zheng P; Wang Y; Liu M; Zhao W; Xiao TS; Zhou Y; Jin T
Front Immunol; 2022; 13():1047922. PubMed ID: 36426349
[TBL] [Abstract][Full Text] [Related]
7. Oxidized thioredoxin 1 places a leash on NLRP1 inflammasome activity.
Yap JK; Emming S; Schroder K
Immunol Cell Biol; 2024 Jan; 102(1):5-7. PubMed ID: 37946689
[TBL] [Abstract][Full Text] [Related]
8. Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding.
Zhong FL; Robinson K; Teo DET; Tan KY; Lim C; Harapas CR; Yu CH; Xie WH; Sobota RM; Au VB; Hopkins R; D'Osualdo A; Reed JC; Connolly JE; Masters SL; Reversade B
J Biol Chem; 2018 Dec; 293(49):18864-18878. PubMed ID: 30291141
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for distinct inflammasome complex assembly by human NLRP1 and CARD8.
Gong Q; Robinson K; Xu C; Huynh PT; Chong KHC; Tan EYJ; Zhang J; Boo ZZ; Teo DET; Lay K; Zhang Y; Lim JSY; Goh WI; Wright G; Zhong FL; Reversade B; Wu B
Nat Commun; 2021 Jan; 12(1):188. PubMed ID: 33420028
[TBL] [Abstract][Full Text] [Related]
10. The interaction between NLRP1 and oxidized TRX1 involves a transient disulfide bond.
Geeson MB; Hsiao JC; Tsamouri LP; Ball DP; Bachovchin DA
Cell Chem Biol; 2024 May; 31(5):955-961.e4. PubMed ID: 38215746
[TBL] [Abstract][Full Text] [Related]
11. The NLRP1 Inflammasome in Human Skin and Beyond.
Fenini G; Karakaya T; Hennig P; Di Filippo M; Beer HD
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640751
[TBL] [Abstract][Full Text] [Related]
12. Tripping the wire: sensing of viral protease activity by CARD8 and NLRP1 inflammasomes.
Castro LK; Daugherty MD
Curr Opin Immunol; 2023 Aug; 83():102354. PubMed ID: 37311351
[TBL] [Abstract][Full Text] [Related]
13. DPP9's Enzymatic Activity and Not Its Binding to CARD8 Inhibits Inflammasome Activation.
Griswold AR; Ball DP; Bhattacharjee A; Chui AJ; Rao SD; Taabazuing CY; Bachovchin DA
ACS Chem Biol; 2019 Nov; 14(11):2424-2429. PubMed ID: 31525884
[TBL] [Abstract][Full Text] [Related]
14. M24B aminopeptidase inhibitors selectively activate the CARD8 inflammasome.
Rao SD; Chen Q; Wang Q; Orth-He EL; Saoi M; Griswold AR; Bhattacharjee A; Ball DP; Huang HC; Chui AJ; Covelli DJ; You S; Cross JR; Bachovchin DA
Nat Chem Biol; 2022 May; 18(5):565-574. PubMed ID: 35165443
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment.
Sharif H; Hollingsworth LR; Griswold AR; Hsiao JC; Wang Q; Bachovchin DA; Wu H
Immunity; 2021 Jul; 54(7):1392-1404.e10. PubMed ID: 34019797
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide and other arsenical compounds inhibit the NLRP1, NLRP3, and NAIP5/NLRC4 inflammasomes.
Maier NK; Crown D; Liu J; Leppla SH; Moayeri M
J Immunol; 2014 Jan; 192(2):763-70. PubMed ID: 24337744
[TBL] [Abstract][Full Text] [Related]
17. The NLRP1 inflammasomes.
Chavarría-Smith J; Vance RE
Immunol Rev; 2015 May; 265(1):22-34. PubMed ID: 25879281
[TBL] [Abstract][Full Text] [Related]
18. Role of the NLRP1 inflammasome in skin cancer and inflammatory skin diseases.
Calabrese L; Fiocco Z; Mellett M; Aoki R; Rubegni P; French LE; Satoh TK
Br J Dermatol; 2024 Feb; 190(3):305-315. PubMed ID: 37889986
[TBL] [Abstract][Full Text] [Related]
19. P38 kinases mediate NLRP1 inflammasome activation after ribotoxic stress response and virus infection.
Jenster LM; Lange KE; Normann S; vom Hemdt A; Wuerth JD; Schiffelers LDJ; Tesfamariam YM; Gohr FN; Klein L; Kaltheuner IH; Ebner S; Lapp DJ; Mayer J; Moecking J; Ploegh HL; Latz E; Meissner F; Geyer M; Kümmerer BM; Schmidt FI
J Exp Med; 2023 Jan; 220(1):. PubMed ID: 36315050
[TBL] [Abstract][Full Text] [Related]
20. The cyclopentenone prostaglandin 15d-PGJ2 inhibits the NLRP1 and NLRP3 inflammasomes.
Maier NK; Leppla SH; Moayeri M
J Immunol; 2015 Mar; 194(6):2776-85. PubMed ID: 25681332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
